Kiadis to Host Key Opinion Leader Meeting on Addressing the Risks of Haloidentical HSCT in Blood Cancer
Sage Therapeutics Announces First Quarter 2017 Financial Results and Provides Pipeline Update
Agilis Biotherapeutics Expands Commercial, Medical Teams
bluebird bio Reports First Quarter 2017 Financial Results and Recent Operational Progress
Kiadis Pharma Announces Filing of Marketing Authorization with the European Medicines Agency for ATIR101™ in Blood Cancers
Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...